Citigroup Inc Instil Bio, Inc. Transaction History

Citigroup Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.4 - $0.63 $536 - $844	-1,341 Reduced 43.51%	1,741 $0
Q2 2023 Aug 10, 2023	SELL	$0.51 - $0.67 $2.05 Million - $2.7 Million	-4,026,657 Reduced 99.92%	3,082 $1,000
Q1 2023 May 11, 2023	BUY	$0.6 - $0.91 $2.42 Million - $3.66 Million	4,027,315 Added 166143.36%	4,029,739 $2.66 Million
Q4 2022 Feb 09, 2023	SELL	$0.48 - $5.33 $408 - $4,530	-850 Reduced 25.96%	2,424 $1,000
Q3 2022 Nov 10, 2022	SELL	$4.65 - $7.37 $16,767 - $26,576	-3,606 Reduced 52.41%	3,274 $15,000
Q2 2022 Aug 10, 2022	BUY	$4.21 - $11.15 $8,310 - $22,010	1,974 Added 40.24%	6,880 $32,000
Q1 2022 May 12, 2022	SELL	$8.48 - $18.1 $106,831 - $228,023	-12,598 Reduced 71.97%	4,906 $53,000
Q4 2021 Feb 10, 2022	BUY	$15.37 - $22.5 $216,993 - $317,655	14,118 Added 416.95%	17,504 $299,000
Q3 2021 Nov 10, 2021	BUY	$15.05 - $23.28 $50,959 - $78,826	3,386 New	3,386 $61,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $8.8B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.